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Abstract
 
After accumulation of target cell human leukocyte antigen (HLA)-C at inhibitory natural killer
(NK) cell immune synapses, some HLA-C transfers from target cells to NK cell plasma mem-
branes and cytoplasm. This unexpected intercellular transfer of HLA-C is dependent on NK
receptor recognition, since HLA-Cw6 or -Cw4 but not -Cw3 transfer to an NK transfectant
expressing killer Ig-like receptor (KIR)2DL1. Strikingly, live-cell time-lapse laser scanning
confocal microscopy shows vesicles containing target cell green fluorescent protein–tagged
HLA-C migrating away from immune synapses into NK cells. Unlike clustering of HLA-C at
the immune synapse, intercellular transfer of HLA-C is dependent on NK cell ATP, but not
target cell ATP. However, the intercellular transfer of HLA-C is not dependent on active po-
lymerization of the actin cytoskeleton. In addition, different arrangements of HLA-C are seen
at inhibitory NK immune synapses, and these alter as NK synapses mature, but in a fashion dis-
tinct from that seen upon T cell activation.
Key words: MHC class I • KIR • green ﬂuorescent protein • immunosurveillance • laser 
scanning confocal microscopy
 
Introduction
 
As an essential component of the innate immune system,
NK cells participate in cytokine production and cytotoxic-
ity against tumor and virus-infected cells independent of
prior antigen stimulation (1). One way that NK cells survey
a cell’s state of health is to check for expression of MHC
class I protein. This strategy for detecting diseased cells, to
check for an error in the expression of self-proteins rather
than directly detecting nonself molecules, is called the
‘missing self’ hypothesis (2). Human NK cells detect MHC
class I protein via a variety of Ig-like and C-type lectin re-
ceptors (for a review, see references 3–6). Killer Ig-like re-
ceptors (KIRs)
 
*
 
 with two Ig domains, KIR2DL1 and
KIR2DL2 recognize the MHC class I proteins, HLA-Cw4
or -Cw6, and HLA-Cw3 or -Cw7, respectively (7, 8). At
intercellular contacts between NK and target cells, i.e., at NK
cell immune or immunological synapses, KIRs accumulate
with their cognate MHC class I ligands in membrane
domains segregated from domains containing intercellular
adhesion molecule 1 and lymphocyte function–associated
antigen 1 (9). Oligomerization of KIRs in the presence of
cobalt or zinc (10–13) may facilitate such KIR/MHC ag-
gregation at immune synapses (9, 14, 15).
Various immune receptors redistribute at the cell surface
during immunosurveillance (16–19). T cell receptors and
adhesion molecules cluster in unexpectedly large segregated
membrane domains, i.e., supramolecular activation clusters,
at immune synapses (20). In a model system using T cells
interacting with protein-rich two dimensional lipid bilay-
ers, peptide–MHC proteins were seen to initially accumu-
late in a ring around adhesion proteins and then move into
a central patch upon recognition by TCRs (21). These and
other observations (22, 23) suggest an important role in
controlling T cell signaling (24–26), though the context in
which immune synapse formation is important in vivo re-
mains to be clarified (27, 28). Interestingly, the inhibitory
NK cell immune synapse has inverted arrangements of
MHC, intercellular adhesion molecule 1, and lymphocyte
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function associated antigen 1 in comparison to the mature
activating T cell synapse (9, 20, 21; for a review, see refer-
ence 26). Here, we employed live-cell time-lapse laser
scanning confocal microscopy (LSCM) to visualize in
greater detail, the molecular recognition of HLA-C at hu-
man NK cell immune synapses. Unexpectedly, we ob-
served intercellular transfer and dynamic organization of
HLA-C at inhibitory human NK cell immune synapses.
 
Materials and Methods
 
Cell Lines and Transfectants.
 
721.221, an EBV-transformed B
cell line selected to lack endogenous expression of MHC class I
protein (29), was transfected to express COOH-terminal green
fluorescent protein (GFP; reference 30)-tagged HLA-Cw3, -Cw4,
and -Cw6, as described previously (9). 721.221 transfected with
COOH-terminal GFP-tagged HLA-Cw6-TMG, i.e., HLA-Cw6
with the transmembrane region from HLA-G was also described
previously (9). NK transfectants, YTS/Eco and YTS/KIR2DL1,
were also described previously (31).
 
Preparation of Peripheral Blood NK Cells.
 
NK cells were ac-
quired from lymphocyte-enriched buffy coat residues derived
from multiple healthy donors (National Blood Transfusion Ser-
vice, London, UK). PBMCs were isolated from the buffy coat by
centrifugation on Ficoll-Paque Plus (Amersham Pharmacia Bio-
tech) according to the manufacturer’s instructions. Peripheral
blood lymphocytes were cultured with irradiated (20,000 rad)
721.221 cells in a 4:3 ratio (10
 
6
 
 PBL: 7.5
 
 
 
10
 
5
 
 irradiated 721.221/
ml) for the generation of NK lines. The culture medium con-
sisted of RPMI 1640 (GIBCO BRL) with 10% human serum
(type AB; Sigma-Aldrich) supplemented with 1 mM 
 
L
 
-glutamine,
1 mM sodium pyruvate, 1 mM penicillin-streptomycin, 1 mM
MEM nonessential amino acids, and 20 
 
 
 
M 
 
 
 
-mercaptoethanol
(GIBCO BRL). 6–7 d later, pure NK cell cultures were obtained
by removal of contaminating T cells stained with anti-CD3 mAb
(UCHT1; BD PharMingen) by FACS
 
®
 
 (Beckman Coulter). Pure
CD3
 
 
 
CD56
 
 
 
 NK lines were cultured in RPMI 1640 (GIBCO
BRL) with 10% human serum (type AB; Sigma-Aldrich) supple-
mented with 1 mM 
 
L
 
-glutamine, 1 mM sodium pyruvate, 1 mM
penicillin-streptomycin, 1 mM MEM nonessential amino acids,
20 
 
 
 
M 
 
 
 
-mercaptoethanol (GIBCO BRL), and 100 U/ml h-r-
IL-2 (Roche Laboratories) and stimulated with irradiated 721.221
cells in a 4:3 ratio (10
 
6
 
 PBL: 7.5
 
 
 
10
 
5
 
 irradiated 721.221 cells/ml)
immediately after sorting. NK cells were restimulated every 5–6 d
with fresh medium containing IL-2. NK lines were phenotyped
with respect to the levels of expression of CD16 (3G8; BD
PharMingen), KIR2DL1 (HP3E4; BD PharMingen), KIR2DL2
(DX27; BD PharMingen) Ig-like Transcript-2 (HP-F1, a gift
from M. López-Botet, Universitat Pompeu Fabra, Barcelona,
Spain) and were periodically monitored to be CD3-negative and
CD56-positive by antibody staining (with mAb UCHT1 and
B159; BD PharMingen).
 
LSCM.
 
For live-cell imaging, NK cells and target cells (
 
 
 
10
 
6
 
of each) were resuspended in 1 ml tissue culture medium con-
taining no selective antibiotics. The cells were mixed and incu-
bated in conical end centrifuge tubes for 45 min at 37
 
 
 
C, 5%
CO
 
2
 
 unless otherwise indicated. After incubation, cells had fallen
under gravity to the bottom of the tube. Cells were not centri-
fuged together, as in previous work (9). Excess media was re-
moved and the cells were resuspended in 
 
 
 
50 
 
 
 
l tissue culture
medium and 7 
 
 
 
l was sealed between a plain glass slide and
cover-slip. Live cells were imaged immediately by LSM510
(Zeiss) or TCS SP2 (Leica) using a 40
 
 
 
 oil-immersion objective
(numerical aperture 1.3 or 1.25). For 3D reconstructions of inter-
acting cells, images were taken every 0.3 
 
 
 
m through the axis
perpendicular to intercellular contact. A composite of these im-
ages was then either color coded for depth or projected as a 3D
model of the cell conjugate.
Superior images to those seen previously (9) were obtained as
the designs of the microscopes used have various features ensur-
ing maximum light yield and high quality images. This is
achieved by Digital Signal Processors, accurate centration of
pinholes, new scanning mirrors, Acousto-Optical Tunable Fil-
ters, and fiber optic feeds for laser excitation, short light paths
with improved dichroic mirrors and highly sensitive photomul-
tipliers.
Percentages of the total amount of MHC at the synapse and
within the NK cell were obtained by calculating the mean fluo-
rescence intensity within various regions within cell conjugates.
Numbers of synapses, occurrence of intercellular transfer of
HLA-C and different distributions of HLA-C were acquired by
scanning samples using transmitted light views, and characterizing
any conjugates seen by their distribution of fluorescence. 721.221
transfectants were easily distinguished from NK cells or NK
transfectants by their size and/or their bright GFP fluorescence.
In all time-lapse images, zero times are arbitrarily defined.
 
Western Blot Analysis.
 
0.5 
 
 
 
 10
 
6
 
 YTS/KIR2DL1 cells were
previously incubated with 0.5 
 
 
 
 10
 
6
 
 cells of either 221/Cw6-
GFP or 221/Cw3-GFP and then purified by FACS
 
®
 
. These were
then lysed in NuPage™ sample buffer (Invitrogen) containing
the reducing agent DTT and analyzed by SDS-PAGE. Proteins
were transferred to nitrocellulose and the membrane blocked
with 5% milk powder in 0.1% Tween 20/PBS for 1 h. The blot
was stained with anti-GFP mAb (JL-8; CLONTECH) diluted
1:7,000 in blocking solution, washed three times in 0.1% Tween
20/PBS, stained for 1 h with HRP-conjugated goat anti–mouse
Ig (Pierce Chemical Co.), diluted 1:50,000 in blocking solution,
and finally washed five times in 0.1% Tween 20/PBS. Immu-
noreactive bands were visualized by chemiluminescence accord-
ing to manufacturer’s instructions (SuperSignal West Pico; Pierce
Chemical Co.).
 
Depletion of ATP and Impairment of Actin Cytoskeleton.
 
Stock
solutions of reagents (all purchased from Sigma-Aldrich unless
otherwise stated) were made up as follows: 3 M sodium azide in
deionized water, 13 mM antimycin-A in DMSO, 1 mM cyto-
chalasin D in DMSO, and 200 mM 2, 3-butanedione monoxime
(BDM) in PBS, pH 7.4. For the depletion of ATP, NK and tar-
get cells where preincubated separately at 37
 
 
 
C, 5% CO
 
2
 
 in tissue
culture medium with 50 mM sodium azide for 2 h, or glucose-
free RPMI 1640 (Sigma-Aldrich) with 13 
 
 
 
M antimycin-A for
1 h. Where the drug was used to deplete ATP in both cells, the
NK and target cells where then mixed together and incubated for
a further hour. Where the drug was only used in one population
of cells (i.e., the NK or target cells), the cells were first washed
and resuspended in tissue culture medium, or glucose-free RPMI
1640 (Sigma-Aldrich) if antimycin-A was used, and then mixed
together. The cytoskeletal inhibitor, cytochalasin D, which caps
the end of actin microfilaments (32), was used in a similar
method to the other drugs but added to both cell populations at a
concentration of 10 
 
 
 
M and incubated for 1 h before the cells
were mixed. BDM, which is known to target myosin and potas-
sium channels (33, 34), was used at a final concentration of 20
mM in tissue culture medium and the cells were incubated sepa-
rately for an hour before they were mixed and incubated to-
gether for a further hour. 
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Staining with mAbs.
 
Live YTS/KIR2DL1 and 221/Cw6-
GFP cells were mixed and incubated as described previously,
then fixed and permeabilized with Cytofix/Cytoperm (BD
PharMingen) according to manufacturer’s instructions. Cells were
then incubated with 0.5% Triton X-100/PBS (pH 7.4) for 15
min before blocking with 5% BSA/0.1% Tween 20/PBS for 1 h
at room temperature. Cells were then labeled with HC10 (pan
class I MHC mAb; American Type Collection Culture) followed
by Alexa-568
 
®
 
 conjugated goat anti–mouse Ig (Molecular
Probes) in the blocking solution. After incubations with each an-
tibody, cells were washed three times with 0.1% Tween 20/PBS.
Slides were then prepared as for imaging live cells.
 
Flow Cytometry and FACS
 
®
 
.
 
2 
 
 
 
 10
 
6
 
 NK cells and 2 
 
 
 
 10
 
6
 
target cells were washed and resuspended in 1 ml tissue culture
medium with no selective antibiotics, mixed, and incubated at
37
 
 
 
C, 5% CO
 
2
 
 for 1 h (see Fig. 2 a, b, and d) or various times
(see Fig. 2 c). Cells were then incubated on ice for 5 min and
vortexed gently to split up conjugates. The samples were fixed in
4% paraformaldehyde (Sigma-Aldrich) and stained with a Cy-
Chrome™ conjugated mAb against CD56 (B159; BD PharMin-
gen) for separation of the CD56-positive population by FACS
 
®
 
.
Cells were analyzed by flow cytometry (CELLQuest™; Becton
Dickinson).
 
Online Supplemental Material.
 
Fig1cVideo1 and Fig3bVideo2
are movies of time-lapse confocal microscopy data, individual
frames of which are shown in Fig. 1 c and 3 b, respectively.
Fig6bVideo3 is a 360
 
 
 
 rotating projection around the y-axis of the
cells in Fig. 6 b. Fig6cVideo4 is a 360
 
 
 
 rotating projection of the
cells at the first time point of Fig. 6 c.
 
Results
 
Peripheral Blood NK Cell Lines Capture Target Cell
HLA-C.
 
A CD56
 
 
 
CD16
 
 
 
CD3
 
 
 
 NK cell line, K010,
derived from peripheral blood of healthy donors, was phe-
notyped by flow cytometry. 50% of cells in this line were
found to express KIR2DL1 (or KIR2DS1, since the mAb
used cannot distinguish the intracellular portion of KIR), 39%
expressed KIR2DL2 (or KIR2DS2), and 0% expressed Ig-
like Transcript 2. After incubation for 30 min at 37
 
 
 
C, 5%
CO
 
2
 
, with transfectants of 721.221 expressing GFP-conju-
gated HLA-Cw6 (221/Cw6-GFP), clustering of GFP was
seen in 
 
 
 
50% of NK/target cell intercellular contacts. This
is consistent with KIR2DL1-induced clustering of HLA-
Cw6 at NK immune synapses as described previously (9).
However, when imaging live conjugates of NK and 221/
Cw6-GFP cells by confocal microscopy in the current
study, GFP-tagged HLA-Cw6 (HLA-Cw6-GFP) could
also be seen on the NK cell, both at the cell surface and in
small intracellular vesicles, only in conjugates at which in-
hibitory synapses were evident. Two peripheral blood NK
cells simultaneously surveying a single 221/Cw6-GFP cell
can be seen in Fig. 1 a. HLA-C has transferred only into
the NK cell at which HLA-C clustered at the immune syn-
apse, consistent with KIR2DL1-induced clustering and in-
tercellular transfer of HLA-Cw6.
Images taken every 0.3 
 
 
 
m through cell conjugates, per-
pendicular to the immune synapses revealed that much of
the captured HLA-Cw6-GFP is on the NK plasma mem-
brane with some in the cytoplasm. This is represented in
Figure 1. HLA-Cw6-GFP transfers from target cells to NK cells at the
inhibitory NK immune synapse. (a) A single 221/Cw6-GFP cell is seen
interacting with two peripheral blood NK cells (NK line K010) demon-
strating selective clustering and intercellular transfer of HLA-Cw6-GFP at
the immune synapse. Figure shows the transmitted light overlaid with
GFP fluorescence (left) and the corresponding GFP fluorescence only
(right). Clustering of HLA-Cw6-GFP at the immune synapse and trans-
ferred vesicles of GFP are evident in the lower K010 NK cell only. (b)
Vesicles containing HLA-Cw6-GFP, transferred from the target cell to
the NK cell, are present on the NK cell surface and cytoplasm. Left panel
shows a single 0.9  m optical slice of GFP fluorescence in a K010 NK
cell conjugated to a 221/Cw6-GFP target cell (bottom of the panel).
HLA-Cw6-GFP is clustered at the immune synapse and there is also
transfer of HLA-Cw6-GFP onto the NK cell surface. Images were taken
every 0.3  m through the cell perpendicular to the immune synapse and
a composite of these images was then color coded for depth through the
NK cell (right). The color scale used is below the panel; 0  m (blue) rep-
resents the upper surface and 3.5  m (red) the lower surface of the NK
cell. Red and white arrows indicate vesicles containing HLA-Cw6-GFP
on the plasma membrane and in the cytoplasm of the NK cell, respec-
tively. (c) Top panel shows the transmitted light image overlaid with GFP
fluorescence; lower three frames depict identical fields of view at different
times, showing a vesicle containing HLA-Cw6-GFP moving away from
the immune synapse into the NK cell. The white arrow indicates the po-
sition of the vesicle in the first frame. In all images, white scale bars repre-
sent 5  m. Cells shown are representative of numerous cells in at least
three independent experiments. 
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Fig. 1 b (right), in which GFP fluorescence has been col-
ored according to its depth within the NK cell. Blue- and
red-colored patches represent GFP fluorescence located on,
or near to, the upper and lower NK cell surfaces, respec-
tively. Green colored patches locate GFP 
 
 
 
1.5–2 
 
 
 
m be-
neath the upper cell surface within the cytoplasm.
Using time-lapse imaging, vesicles containing HLA-
Cw6-GFP are clearly seen migrating away from the im-
mune synapse and into the cytoplasm of an NK cell from
another peripheral blood NK cell line, K007, which ex-
presses KIR2DL1 (Fig. 1 c and Fig1cVideo1). Vesicles mi-
grated with nonBrownian direction, reminiscent of migra-
tion of vesicles along the cytoskeleton. The speed of one of
these vesicles, or group of vesicles, at room temperature
was calculated to be 0.04 
 
 
 
m s
 
 
 
1
 
.
 
NK Cell Transfectants Expressing KIR2DL1 Capture Target
Cell HLA-C.
 
To determine if intercellular transfer of
HLA-C is dependent on recognition by KIRs, we used a
CD28
 
 
 
 NK tumor line YTS, which does not endoge-
nously express known KIRs, transfected with the ecotropic
receptor (YTS/Eco) and subsequently mock transfected
(YTS/Mock) or transfected using a retrovirus to express
KIR2DL1 (YTS/KIR2DL1; reference 31). These cells
were incubated with 221/Cw3-GFP, 221/Cw4-GFP, or
221/Cw6-GFP target cells and subsequently imaged for
evidence of clustering and intercellular transfer of HLA-C
at NK immune synapses. HLA-Cw6-GFP transferred into
and onto YTS/KIR2DL1 but not to YTS/Eco or YTS/
Mock whereas HLA-Cw3-GFP did not transfer to YTS/
KIR2DL1 (Table I). HLA-Cw4-GFP also transferred to
YTS/KIR2DL1, demonstrating that intercellular transfer
of HLA-C is not exclusive to HLA-Cw6. Flow cytometry
also revealed that YTS/KIR2DL1 cells incubated with
221/Cw6-GFP targets exhibited greater GFP fluorescence
than those incubated with 221/Cw3-GFP targets (Fig. 2 a
and b). The GFP fluorescence in YTS/KIR2DL1 incu-
bated with 221/Cw6-GFP steadily increased 
 
 
 
1 h (Fig. 2
c). YTS/KIR2DL1 cells incubated with 221/Cw6-GFP or
221/Cw3-GFP targets, and YTS/Eco incubated with 221/
Cw6-GFP, were purified by FACS
 
®
 
. Purified YTS/
KIR2DL1 cells that were incubated with 221/Cw6-GFP
targets had higher GFP fluorescence intensity than the
other two NK populations (Fig. 2 d). Since KIR2DL1 rec-
ognizes HLA-Cw4 and -Cw6 but not -Cw3, these data
demonstrate that intercellular transfer of HLA-C is depen-
dent upon NK receptor recognition.
To determine if the whole HLA-Cw6-GFP protein
transfers to NK cells, YTS/KIR2DL1 was isolated by
FACS
 
®
 
 after incubation with 221/Cw6-GFP or 221/Cw3-
GFP. Lysates of the sorted NK cells were then analyzed by
SDS-PAGE and Western blot analysis with an anti-GFP
mAb (JL-8). A band corresponding to the full size of HLA-
Cw6-GFP was evident in the lane containing the lysate of
YTS/KIR2DL1 incubated with 221/Cw6-GFP but no
band was seen in the lane containing the lysate of YTS/
KIR2DL1 cells incubated with 221/Cw3-GFP (Fig. 2 e),
in accordance with the specificity of KIR2DL1. The posi-
tion of the band is also consistent with the molecular
weight predicted from the sequence of HLA-Cw6-GFP,
further indicating that transfer of the whole HLA-Cw6-
GFP protein occurs.
YTS/KIR2DL1 was also able to capture HLA-Cw6-
GFP in which the transmembrane sequence was replaced
Figure 2. Transfer of HLA-Cw6
transfer between populations of NK and
target cells analyzed by flow cytometry.
YTS/KIR2DL1 cells were incubated
with either (a) 221/Cw3-GFP or (b)
221/Cw6-GFP for 1 h and subsequently
fixed, stained for CD56, and analyzed
by flow cytometry. Plots show level of
CD56 expression (y-axis) against the
level of GFP fluorescence (x-axis).
CD56  YTS/KIR2DL1 cells incubated
with 221/Cw6-GFP targets have brighter GFP fluorescence compared
with those incubated with 221/Cw3-GFP. (c) YTS/KIR2DL1 cells were
incubated for 0, 20, 40, and 60 min with 221/Cw6-GFP or 221/Cw3-GFP
targets. HLA-Cw6-GFP levels within purified YTS/KIR2DL1 populations
were assessed by flow cytometry. Closed circles represent YTS/KIR2DL1
cells that were incubated with 221/Cw6-GFP targets and the open circles
represent those incubated with 221/Cw3-GFP. Increasing median fluo-
rescence intensity over time was observed in the case of YTS/KIR2DL1
cells incubated with 221/Cw6-GFP targets compared with those incu-
bated with 221/Cw3-GFP. Data are representative of three separate ex-
periments. (d) YTS/KIR2DL1 cells were incubated with either (i) 221/
Cw3-GFP, (ii) 221/Cw6-GFP, or (iii) YTS/Eco with 221/Cw6-GFP for
1 h and subsequently fixed, stained for CD56, sorted by FACS®, and ana-
lyzed by flow cytometry. Plot shows number of cells (y-axis) against the
level of GFP fluorescence (x-axis). CD56  YTS/KIR2DL1 cells incu-
bated with 221/Cw6-GFP targets have brighter GFP fluorescence com-
pared with those incubated with 221/Cw3-GFP or compared with
YTS/Eco incubated with 221/Cw6-GFP. (e) YTS/KIR2DL1 prein-
cubated with both 221/Cw6-GFP and 221/Cw3-GFP were isolated
by FACS®, lysed, and the total protein analyzed by SDS-PAGE fol-
lowed by Western blot analysis with anti-GFP mAb. Lane 1 contains
221/Cw6-GFP cell lysate to indicate the size of HLA-Cw6-GFP.
Lanes 2 and 3 are YTS/KIR2DL1 preincubated with 221/Cw6-GFP
and 221/Cw3-GFP, respectively. Blot shown is representative of three
independent experiments. 
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with that of HLA-G, which lacks a critical transmembrane
cysteine (221/Cw6-TMG-GFP; Table I). Thus, although
recognition of HLA-Cw6 by a subset of NK cells is depen-
dent on a cysteine within the transmembrane sequence
(Cys309; reference 35), capture of HLA-Cw6 by YTS/
KIR2DL1 is independent of this substitution.
Like the transfer of HLA-C into peripheral blood NK
cells (Fig. 1), target cell HLA-Cw6-GFP transferred to
both the plasma membrane and the cytoplasm of YTS/
KIR2DL1 (Fig. 3 a). In time-lapse images, target cell HLA-
Cw6-GFP was seen moving away from the immune syn-
apse and into YTS/KIR2DL1, both from the center of the
immune synapse into the cytoplasm of YTS/KIR2DL1
(Fig. 3 b) and from the edge of the synapse directly onto
the NK cell surface (Fig. 3 c). Transfer of target cell HLA-
Cw6-GFP into YTS/KIR2DL1 was seen at both room
temperature (Fig. 3 b, Fig3cVideo2 and Fig. 3 c) and at
37
 
 
 
C, using a heated microscope stage (Fig. 3 d). However,
it proved difficult to routinely image cells at 37
 
 
 
C due to
cell movement during image acquisition. Confirming that
the GFP transferred to NK cells marks the location of
HLA-C, a mAb against class I MHC protein, HC10 (36),
was also found to colocalize in the vesicles containing GFP
(Fig. 4).
Quantification of transferred HLA-Cw6-GFP was achieved
by software analysis of the mean fluorescence intensity
within defined areas. Boundaries within an image were
defined around the whole conjugate, the immune syn-
apse, and the NK cell, and the fluorescence in each of these
regions was used to calculate the fraction of the total HLA-
Cw6-GFP that accumulated at the NK immune synapse,
and transferred to the NK cell. In five NK immune syn-
apses between YTS/KIR2DL1 and 221/Cw6-GFP, the
amount of HLA-Cw6-GFP accumulated at the synapse was
found to be 24, 10, 17, 31, and 27% of the total HLA-
Cw6-GFP in the conjugate. In each of these five synapses,
the respective amount of HLA-Cw6-GFP transferred to
the NK cell was found to be 28, 6, 13, 6, and 22%, of the
total HLA-Cw6-GFP in the conjugate. Thus, it is likely
that variable amounts of target cell HLA-C transfer to NK
cells, independent of the amount accumulated at the im-
mune synapse. However, differences in the amount of
HLA-C transferred into the NK cells could also be ac-
counted for if each NK cell, before imaging, surveyed a
variable number of target cells capturing some HLA-C
from each.
 
Depletion of NK Cell ATP but not Target Cell ATP Inhibits
Intercellular Transfer of HLA-Cw6-GFP.
 
Sodium azide and
antimycin-A have been shown to deplete ATP in the cell
lines used by 94 and 97%, respectively (9). Here, the num-
ber of conjugates that exhibited clustering of HLA-Cw6-
GFP at the immune synapse and the transfer of HLA-Cw6-
GFP from 221-Cw6-GFP to YTS/KIR2DL1 cells were
quantified with or without the addition of these drugs. Pre-
viously, clustering of MHC at the NK immune synapse
was observed to be independent of ATP depletion (9).
Here however, live-cell confocal microscopy showed that
ATP is required by the NK cell for intercellular transfer of
HLA-C to take place (Fig. 5 a and b). This infers that inter-
cellular transfer of HLA-C is an active process by the NK
cell, independent of the target cell ATP.
 
Cytoskeletal Impairment Has no Effect on the Number of
Conjugates where Transfer of HLA-Cw6-GFP Occurs.
 
The
number of conjugates between YTS/KIR2DL1 and 221-
Cw6-GFP cells where HLA-Cw6-GFP was transferred to
the NK cell were also counted with or without the addi-
tion of cytoskeletal inhibitors. Cytochalasin D caps actin
microfilaments stopping their interaction with other sub-
units (32) and BDM has been shown to impair receptor re-
distribution at the T cell immune synapse (17). However,
neither cytochalasin D nor BDM addition had any effect
on the number of cell conjugates in which transfer of
HLA-C was observed (Fig. 5 c). Therefore, even though
live-cell time-lapse imaging of transfer and uptake of HLA-
C-GFP by NK cells showed movement of vesicles reminis-
cent of travel along the cytoskeleton (Fig. 1 c and
 
Table I.
 
Inhibitory KIRs Induce Capture of Target Cell HLA-C
 
NK cell Target cell
Number of 
conjugates imaged
Percentage of conjugates 
exhibiting clustering of GFP 
at the immune synapse
Percentage of conjugates 
showing transfer of GFP 
to NK cell
YTS/KIR2DL1 221/Cw6-GFP 415 66 49 (74)
YTS/ECO 221/Cw6-GFP 207 2 5
YTS/MOCK 221/Cw6-GFP 122 2 2
CW4 YTS/KIR2DL1 221/CW4-GFP 20 80 65 (81)
CW4-TMG YTS/KIR2DL1 221/CW6TMG-GFP 89 76 48 (63)
YTS/KIR2DL1 221/Cw3-GFP 174 5 3
Various transfectants of 721.221 were imaged when conjugated to various YTS transfectants as listed. Table lists the percentage of cell conjugates for
which GFP-tagged HLA-C clustered at the intercellular contact and the percentage of cell conjugates for which HLA-Cw6-GFP transferred to the
NK cell. Numbers in parenthesis denote the percentage of those conjugates exhibiting clustering of GFP at the immune synapse that also show transfer
of GFP into the NK cell. 
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Fig1cVideo1), active polymerization of actin and myosin
operation, does not appear necessary for the process.
 
Distributions of HLA-C at Inhibitory NK Cell Immune Syn-
apses.
 
Live-cell microscopy and 3D reconstruction of in-
teracting cells, showed various distributions of HLA-Cw6-
GFP at immune synapses between peripheral blood NK
cells and 221/Cw6-GFP cells (Fig. 6 a, Fig6bVideo3.avi
and Fig6cVideo4). Different distributions of HLA-Cw6-
GFP were also seen at inhibitory immune synapses be-
tween YTS/KIR2DL1 and 221/Cw6-GFP cells. Strik-
ingly, two distinct distributions of HLA-Cw6-GFP were
produced by a single YTS/KIR2DL1 cell, simultaneously
forming two inhibitory immune synapses with two differ-
ent target cells (Fig. 6 b, Fig6bVideo3, and Fig6cVideo4).
HLA-Cw6-GFP has also clearly transferred to this YTS/
KIR2DL1 cell (Fig. 6 b and Fig6bVideo3).
Moreover, distributions of HLA-Cw6-GFP at some im-
mune synapses were found to change over time, such that
patches within the immune synapse devoid of HLA-Cw6-
GFP appeared and disappeared as synapses matured (Fig. 6
c). Thus, distinct dynamic patterns of segregated protein do-
mains occur at human NK cell immune synapses, even with
cell lines expressing a particular MHC and KIR repertoire.
 
Figure 3.
 
HLA-C transfers from target cells to YTS/KIR2DL1 cells at
the inhibitory NK immune synapse. (a) The left panel shows the GFP
fluorescence of a single YTS/KIR2DL1 cell (center) conjugated to three
221/Cw6-GFP cells (top, bottom, and right), with GFP clustered at each
immune synapse. As in Fig. 1 b, images were taken every 0.3 mm
through the cell perpendicular to the immune synapse and a composite of
these images was then color coded for depth through the YTS/KIR2DL1
cell (right). The color scale used is below the panel; 0 
 
 
 
m (blue) repre-
sents the upper surface and 5 
 
 
 
m (red) the lower surface of the YTS/
KIR2DL1 cell. Red and white arrows point out vesicles containing
HLA-Cw6-GFP on the plasma membrane and in the cytoplasm of the
cell respectively. (b and c) Images of a single YTS/KIR2DL1 cell conju-
gated with 221/Cw6-GFP cells. Top panel shows the transmitted light
image overlaid with GFP fluorescence; lower frames depict the field of
view highlighted in red at three different times. These show a vesicle
containing HLA-Cw6-GFP moving away from the immune synapse and
into the NK cell. (b) The white arrow indicates the position of a vesicle
containing HLA-Cw6-GFP. (c) The red arrow indicates the position of
HLA-Cw6-GFP at the edge of the immune synapse. (d) Two images of a
conjugate between YTS/KIR2DL1 and 221/Cw6-GFP taken at 0 and
19 min at 37
 
 
 
C. The white arrow points to a vesicle containing HLA-Cw6-
GFP migrating from the 221/Cw6-GFP cell into the YTS/KIR2DL1 cell.
In all images, white scale bars represent 5 
 
 
 
m. Cells shown are representa-
tive of numerous cells in at least five independent experiments.
Figure 4. Target cell GFP transferred into YTS/KIR2DL1 colocalizes
with MHC class I protein. YTS/KIR2DL1 and 221/Cw6-GFP cell con-
jugates were fixed, stained with HC10, a pan-class I MHC mAb, and vi-
sualized with an Alexa-568® conjugated goat anti–mouse Ig (GAM; Mo-
lecular Probes). (a) Transmitted light of a single YTS/KIR2DL1 cell
(center) conjugated to a single 221/Cw6-GFP cell (in top right of panel).
b and c show the (green) GFP and (red) HC10/Alexa-568® GAM fluo-
rescence in same field of view. (d) Overlay of the GFP (green) and
HC10/Alexa-568® GAM (red). Pixels at which HC10 (red) colocalizes
with GFP (green) are colored yellow. The white arrow indicates two ves-
icles containing HC10 and GFP in the YTS/KIR2DL1 cell. White scale
bar represents 5  m. 
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The central and peripheral protein domains at T cell im-
mune synapses are named c- and p-supramolecular activa-
tion clusters (20). In keeping with this terminology, we
name the peripheral and central protein domains at the in-
hibitory NK immune synapse as c- and p-supramolecular
inhibition clusters (SMIC), such that HLA-C appears to ac-
cumulate in the p-SMIC with areas of HLA-C exclusion
being c-SMIC. Inhibitory NK immune synapses could
then be characterized as containing (a) no c-SMIC, (b) a
single c-SMIC, or (c) multiple c-SMIC. Examples of each
are shown in Fig. 6 d. Interestingly, the frequency of each
type of inhibitory synapse was similar, 40, 29, and 31%, re-
spectively (
 
n 
 
  
 
73), for immune synapses formed between
YTS/KIR2DL1 and 221/Cw6-GFP.
 
Discussion
 
In this study, time-lapse LSCM of GFP-conjugated
HLA-C in live cells was used with resolution superior to
that reported previously (9). This directly demonstrated
transfer of HLA-C from target to peripheral blood NK cells
(Fig. 1 and Fig1cVideo1) and variable supramolecular orga-
nization of HLA-C at NK immune synapses (Fig. 6,
Fig6bVideo3, and Fig6cVideo4). Use of NK transfectants
showed NK receptor-dependent transfer of HLA-C from
target to NK cells (Figs. 2 and 3) and dynamic supramolec-
ular organization of HLA-C at NK immune synapses (Fig.
6). Use of sodium azide and antimycin-A to deplete ATP
showed that intercellular transfer of HLA-C is dependent
on NK cell ATP, but not target cell ATP (Fig. 5 a and b).
Use of cytochalasin D or BDM to impair the cells’ cytoskel-
eton had no effect on transfer of HLA-C (Fig. 5 c). These
data demonstrate an unexpected level of high order tempo-
ral and spatial supramolecular organization likely to be im-
portant in the integration of positive and negative signaling
during NK immunosurveillance.
Recent studies investigating T cell–APC interactions
have shown that MHC protein (37–39) and other mem-
brane fragments (40) transfer from target to T cells upon
TCR activation. OX40 ligand may transfer from target
cells to T cells independent of TCR engagement (41). In
addition, B cells have recently been shown to acquire anti-
gen from target cells at a B cell immune synapse, perhaps in
order to process and present membrane-bound antigens to
T cells (42). Thus intercellular protein transfer between
lymphocytes may be common.
The half-life of soluble KIR2DL1 binding to soluble
HLA-C is around 0.3 s, more than an order of magnitude
faster than the binding of TCR to MHC ligands and at
least two orders of magnitude faster than mAb binding
(10). Interestingly however, the half-life of KIR2DL1/
HLA-Cw6 could be similar to TCR/MHC binding, if
KIR2DL1 is clustered in the presence of zinc (11). The
length of time NK cells remain in contact (i.e., the order
of minutes) seems unlikely to be long enough for appre-
ciable amounts of HLA-C to be captured without the in-
duction of an active process by KIRs. This is consistent
Figure 5. Intercellular transfer of HLA-C can be inhibited by depleting
NK cell ATP but not by depleting target cell ATP or by impairing both
cells’ actin cytoskeleton. Plot shows percentage of cell conjugates exhibit-
ing intercellular transfer of HLA-Cw6-GFP as a percentage of those
where clustering of HLA-Cw6-GFP was observed at the immune syn-
apse. Cells were incubated with or without the following drugs as labeled
(a) 50 mM sodium azide, (b) 13  M antimycin-A, (c) 10  M cytochala-
sin D, or 20 mM BDM. Each plot is representative of  100 conjugates
over three independent experiments. 
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with the requirement for NK cell ATP (Fig. 5 a and b).
Thus, the half-life of TCR/MHC and KIR/MHC pro-
teins may be similar in order to facilitate a common mech-
anism of capturing MHC protein from target cells. This
may correlate with internalization of KIR (43) and TCR
(44) after ligation.
It is interesting that vesicles in NK cells and membrane
domains at NK cell surfaces can both contain target cell
HLA-C (Figs. 1, 3, and 4), and it will be important to
characterize these vesicles and domains fully. There is evi-
dence that tumor, dendritic, and EBV-transformed B cells
can secrete vesicles of endosomal origin or ‘exosomes’ (45,
46). However, constitutive secretion of MHC protein in
exosomes is too slow, at 
 
 
 
10% of the total MHC protein
in 24 h (46), to account for the capture of HLA-C by NK
cells reported here.
It has been suggested (37) that transfer of MHC protein
to activated T cells may serve to dampen immune re-
sponses by fratricide, i.e., neighboring T cells killing T cells
expressing captured MHC/antigenic peptide. However, a
similar function for transfer of MHC protein between lym-
phocytes could not be attributed to the transfer of target
cell HLA-C to NK cells, as HLA-C transferred to NK cells
would not usually present an antigenic peptide and, in gen-
eral, HLA-C serves to inhibit rather than activate NK cells.
Alternatively, HLA-C transferred to NK cells could
serve to directly signal inhibition of NK cytotoxicity until
the level of captured HLA-C falls below a certain thresh-
old. However, this would not be consistent with observa-
tions that NK cells cannot be inhibited from killing suscep-
tible targets by the presence of bystander cells expressing
inhibitory HLA-C, i.e., NK cells cannot be inhibited in
trans (8). Instead, we speculate that continually assessing the
level of HLA-C expression, through serial encounter with
neighboring cells, could help set a threshold at which a sin-
gle cell can be determined to express low levels of HLA-C.
Perhaps this could prevent unwanted lysis of healthy cells
of different type with an intrinsic heterogeneity in levels of
HLA-C expression.
An example of how this could work would be if the cap-
tured HLA-C served to simply sequester a key NK mole-
cule required for inhibition, such as the KIRs or the down-
stream Src homology 2 domain–containing tyrosine
phosphatase, (SHP)-1 (47). The amount of KIR/SHP-1
sequestered by captured HLA-C would then depend on
the amount of HLA-C expressed in the area of surveil-
lance. A high level of HLA-C captured during serial en-
counters with several targets would then lead to a high
amount of KIR/SHP-1 being sequestered. This in turn
 
Figure 6.
 
Supramolecular organization of HLA-C at inhibitory NK
immune synapses. (a) Image of 221/Cw6-GFP cells surrounding a pe-
ripheral blood K010 NK cell (left) and the supramolecular organization of
HLA-Cw6-GFP at the two immune synapses formed (right panels). (b)
First panel shows an overlay of HLA-Cw6-GFP fluorescence and the
transmitted light image of a single YTS/KIR2DL1 cell conjugated with
two 221/Cw6-GFP cells (far left of frame). The next three frames depict
a 3D reconstruction of the same cells, demonstrating the formation of
two distinct supramolecular organizations by a single YTS/KIR2DL1
cell. Cartoons below each frame represent the orientation of the interact-
ing cells in each frame, with green spheres representing the 221/Cw6-
GFP cells. (c) Left panel shows the transmitted light image overlaid with
GFP fluorescence of 221/Cw6-GFP cells surrounding a YTS/KIR2DL1
cell. The right panels show the dynamic supramolecular organization of
GFP fluorescence at the two immune synapses indicated. White arrows
indicate SMIC that disappear in the next frame; red arrows indicate new
SMIC that were absent from the previous frame. In all images, white scale
bars represent 5 
 
 
 
m. Cells shown are representative of numerous cells in
at least three independent experiments. d shows the frequency of different
patterns of p- and c-SMIC at the immune synapse between YTS/
KIR2DL1 and 221/Cw6-GFP. Two images of each type of organization,
i.e., no c-SMIC, single c-SMIC, and multiple c-SMIC are shown with
the percentage that each was observed given below. A total of 73 synapses
were analyzed over at least three independent experiments. 
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would then leave a lower amount of KIR/SHP-1 available
for inhibition at a given NK synapse and hence a higher
amount of HLA-C at that immune synapse may then be
required to trigger inhibition.
An emerging theme in contemporary molecular immu-
nology is that cell surface receptors need to be considered
as part of supramolecular complexes of proteins and lipids
that facilitate specific receptor conformations and distinct
distributions at cell surfaces. That different arrangements of
segregated protein domains (Fig. 6) can occur at inhibitory
immune synapses raises a number of important new ques-
tions. For example, does supramolecular organization of
HLA-C at the inhibitory synapse influence the outcome of
the intercellular communication and how is the organiza-
tion biophysically controlled? Clustering of similarly sized
proteins could account for the segregation of protein do-
mains at immune synapses (48, 49), but could not predict
the specific arrangements of such segregated domains seen
at the synapses. It has also been suggested that cell surface
proteins are recruited to a particular localization within cell
membranes through noncovalent interactions with choles-
terol-rich membrane microdomains known as ‘lipid rafts’
(50). Indeed, clustering of lipid rafts induced by costimula-
tion of T cells suggests an immunological importance of
lipid raft motility (51, 52), but their role in immune syn-
apse formation remains to be clarified. However, recent
data shows that engagement of HLA-C by KIR blocks re-
distribution of lipid rafts (53), suggesting that organization
of lipid rafts is not responsible for the different arrange-
ments of HLA-C at NK inhibitory immune synapses seen
in Fig. 6, Fig6bVideo3, and Fig6cVideo4.
In summary, both intercellular transfer and supramolecu-
lar organization of MHC protein at immune synapses em-
body new high order aspects of molecular recognition by
NK cells. The NK immune synapse undoubtedly includes
additional cell surface proteins critical to the intercellular
communication, for example, HLA-E/CD94/NKG2 (54)
the activating NK receptors including NKG2D, NKp44,
NKp46, and NKp30 (55, 56) and their ligands, such as
MIC (57) and viral hemagglutinin (58). An important next
goal is to image the organization of these and other recep-
tors at NK immune synapses.
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